Doctors try to make sense of cancer’s genetic jumble
CHICAGO (Reuters) - Not too long ago, knowing the organ where a cancer first takes hold was generally all a doctor needed to determine what treatments to use. Not anymore....
Home > Reviews
All Stories
Bristol immune drug shows promise in three cancers
CHICAGO (Reuters) - An experimental Bristol-Myers Squibb drug helped shrink tumors in patients with advanced melanoma, kidney and lung cancers in a preliminary trial, raising hopes for yet another drug...
Bristol immune drug shows promise in three cancers
CHICAGO (Reuters) - An experimental Bristol-Myers Squibb drug helped shrink tumors in patients with advanced melanoma, kidney and lung cancers in a preliminary trial, raising hopes for yet another drug...
Roche Alzheimer’s drug picked for major test
CHICAGO (Reuters) - Roche Holding AG's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia - the first such...
U.S. launches ambitious Alzheimer’s plan with research push
CHICAGO (Reuters) - The U.S. government launched a national plan to address Alzheimer's disease on Tuesday with funding for a first prevention study in high-risk patients and tests on an...
U.S. launches ambitious Alzheimer’s plan with research push
CHICAGO (Reuters) - The U.S. government launched a national plan to address Alzheimer's disease on Tuesday with funding for a first prevention study in high-risk patients and tests on an...
Roche Alzheimer’s drug picked for major test
CHICAGO (Reuters) - Roche Holding AG's Genentech unit has won the right to try its experimental Alzheimer's drug crenezumab on people with no signs of dementia - the first such...
Bird flu paper that raised bioterrorism fears published
CHICAGO (Reuters) - The journal Nature has published the first of two controversial papers about laboratory-enhanced versions of the deadly bird flu virus that initially sparked fears among U.S. biosecurity...
Facebook calls on members to flag organ donor status
CHICAGO (Reuters) - Tired of the long wait for a new kidney, Michael Shelling, a 50-year-old video game marketing consultant based in San Diego, decided to take a more active...
Facebook calls on members to flag organ donor status
CHICAGO (Reuters) - Tired of the long wait for a new kidney, Michael Shelling, a 50-year-old video game marketing consultant based in San Diego, decided to take a more active...